NIH-funded research NIH-funded research

A Personalized Methadone Dosing System

Official title: Methadone Dosing System (MDS)

Funded at Cari Health, INC. · NIH-11324767 · Data updated 2026-11-12

This project is creating a new way to figure out the right methadone dose for each person to help them overcome opioid addiction more effectively.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionCari Health, INC.
NIH-funded
Lab location1 site (San Diego, United States)
Project startJuly 1, 2024
Project endJune 30, 2027
Funding year2025
Award (this year)$1,447,789
NIH project number4U44DA059627-02
Project IDNIH-11324767 on NIH RePORTER

Who could benefit from this research

Could help

This approach is designed for individuals seeking treatment for opioid use disorder who are prescribed methadone.

Less likely to help

Patients not undergoing methadone maintenance treatment for opioid use disorder would not directly benefit from this specific dosing system.

What this research studies

Many people trying to stop opioid use face tough withdrawal symptoms, which can make it hard to continue treatment. Methadone is a helpful medicine, but how well it works can vary a lot from person to person due to differences in their body's metabolism. This project aims to develop a new, science-based approach to methadone dosing that considers your unique metabolism. The goal is to find the perfect dose for you, reducing side effects and preventing withdrawal symptoms, to make your journey to recovery smoother.

Why it matters

Potential benefit: If successful, this system could lead to more effective and personalized methadone treatment, helping more patients overcome opioid addiction with fewer withdrawal symptoms and side effects.

How similar studies have gone: Current methadone dosing often follows general guidelines, so this project introduces a novel, personalized approach based on individual metabolism.

Where this research is happening

  • Cari Health, INC.
    San Diego, United States
    Active

Researchers

  • Principal investigator: Schmidle, Patrik — Cari Health, INC.
  • Study coordinator: Schmidle, Patrik

Related research

Other NIH-funded projects on the same topics.

  • Methadone Dosing System to personalize opioid treatment

    A new, science‑based dosing approach aims to tailor methadone treatment for people with opioid use disorder to reduce withdrawal and improve retention.

    NIH research Cari Health, INC. · San Diego, United States · NIH-11330597

  • Improving methadone dosing for opioid addiction treatment

    This study is working on a new way to personalize methadone treatment for people recovering from opioid addiction, so that the dose fits each person's unique metabolism, helping them feel better and stay in treatment longer.

    NIH research Cari Health, INC. · San Diego, United States · NIH-10792827

  • A system to improve methadone treatment for opioid use disorder

    This study is looking at a new way to help people with opioid use disorder by making it easier for them to get their methadone treatment, especially for those who have a hard time going to daily appointments, so they can feel better and have more freedom in their lives.

    NIH research Cari Health, INC. · San Diego, United States · NIH-10786206

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.